Metropolis Healthcare gains on getting nod to acquire balance 35% stake in Histoxpert

12 Aug 2020 Evaluate

Metropolis Healthcare is currently trading at Rs. 1606.35, up by 6.80 points or 0.43% from its previous closing of Rs. 1599.55 on the BSE.

The scrip opened at Rs. 1633.00 and has touched a high and low of Rs. 1646.00 and Rs. 1519.20 respectively. So far 4125 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 2110.00 on 03-Mar-2020 and a 52 week low of Rs. 993.20 on 24-Mar-2020.

Last one week high and low of the scrip stood at Rs. 1780.00 and Rs. 1519.20 respectively. The current market cap of the company is Rs. 8120.11 crore.

The promoters holding in the company stood at 50.81%, while Institutions and Non-Institutions held 39.59% and 9.60% respectively.

Metropolis Healthcare has received approval for the acquisition of balance Equity stake of 35% i.e. 10,50,000 Equity shares of Rs 10 each in Metropolis Histoxpert Digital Services (Histoxpert). The object of acquisition is to ensure complete control over the affairs of Histoxpert and ensure operational efficiency. The Board of Directors of the company at their meeting held on August 11, 2020 has approved the same.

Metropolis Healthcare offers a comprehensive range of clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.

Metropolis Health. Share Price

1863.15 33.65 (1.84%)
24-Apr-2024 14:09 View Price Chart
Peers
Company Name CMP
Aster DM Healthcare 383.75
Apollo Hospital Ent. 6301.00
Max Healthcare Inst 804.20
Narayana Hrudayalay 1260.00
Global Health 1430.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.